Status:
WITHDRAWN
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
Lead Sponsor:
Emory University
Conditions:
Bone Neoplasms
Eligibility:
All Genders
11+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether using mesenchymal stem cells will heal benign bone lesion defects faster than demineralized bone matrix
Detailed Description
Orthobiologics have recently become a mainstay in treating bony defects whether related to trauma, tumor, or other various reconstructive entities.1 Historically, benign bone growths that were excised...
Eligibility Criteria
Inclusion
- Ages \> 11 years
- Benign bone lesion
Exclusion
- Previous surgery
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00851162
Start Date
March 1 2009
End Date
March 1 2010
Last Update
November 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30306